Washington Roundup, February 2013
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.”
You may also be interested in...
While launching a new balloon-based device to treat chronic sinusitis, Entellus Medical Inc. revealed it would release details on an important clinical study in July.
The device center plans to publish the final version of its national device post-market surveillance strategy and select a third-party group to run its MDEpiNet public-private partnership by the end of February.
Gene-sequencing company Illumina has signed a definitive agreement to acquire Verinata Health for up to $450 million, staking its claim in the fast-growing, noninvasive prenatal genetic-testing market.